Mental Health
genomics
Disease & Genomics

Genomind Rolls Out New Genomind Professional PGx Express to Boost Genetic Testing for Mental Health

Genomind, a leading mental health care company integrating personalized medicine into the fields of neurology and psychiatry, launched on August 10, 2019, Genomind Professional PGx Express, an innovative genetic testing service that creates a personalized approach to treating mental health disorders.

By

Genomind

on

July 2, 2019

Workplace Stress
Stress & Resilience

Burnout: A Growing Mental Health Crisis Employers Are Regrettably Dismissing.

The onus lies on employers and executives to prioritize mental health wellness in the workplace. It begins from here. Only then will this crisis begin to fizzle out and work cease from being a race against one’s mental wellbeing

Ayurveda
Worksite Wellness

Ayurveda, Wellness, and the Workplace

By focusing on the important connections between body, mind, and environment, and steering away from a “one-size-fits-all” approach, companies can better structure their wellness offerings to ensure that employees are happy, healthy, engaged and inspired at work

By

Michael Heinrich

on

July 23, 2019

Mental Illness
Mental & Behavioral Health

The Emotional and Financial Toll of Mental Health Related Illness on Employees and Employers

Parents of children with mental health-related issues may find it difficult balancing time between work and a sick child.

By

Genomind

on

July 2, 2019

Mental & Behavioral Health

Mental Health in the LGBTQ Community and Finding Treatment

It’s time to end the stigma surrounding mental health in the LGBTQ community and acknowledge the millions who struggle with intolerance and suffer in silence.

By

Genomind

on

July 2, 2019

Autism
Mental & Behavioral Health

Managing Autism Spectrum Disorder: An Entrepreneur’s Success Story

Chris Tidmarsh, a 30-year-old entrepreneur with degrees in chemistry, environmental studies, the French language and a robust passion for agriculture who also has autism.

By

Genomind

on

July 2, 2019

Go Up